SCHEMBL30849855

SCHEMBL30849855

CCN1CC[C@H](CF)[C@](C)(CO)C1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29207283 0.79 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL27146279 0.79
SCHEMBL30849748 0.75 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL29207293 0.73 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL12424327 0.69 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL21340079 0.67 CDC25A (0.33)
SCHEMBL25348195 0.65
SCHEMBL25348144 0.65
SCHEMBL24997017 0.63 SMN1; SMN2 (0.38) SMN1; SMN2
SCHEMBL8574627 0.63 SMN1; SMN2 (0.40) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117800975-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-04-02 CN disclosed